AAAAAA

   
Results: 1-9 |
Results: 9
A phase II trial of bryostatin 1 in the treatment of metastatic colorectalcancer
Authors: Zonder, JA Shields, AF Zalupski, M Chaplen, R Heilbrun, LK Arlauskas, P Philip, PA
Citation: Ja. Zonder et al., A phase II trial of bryostatin 1 in the treatment of metastatic colorectalcancer, CLIN CANC R, 7(1), 2001, pp. 38-42
Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model
Authors: Mohammad, RM Adsay, NV Philip, PA Pettit, GR Vaitkevicius, VK Sarkar, FH
Citation: Rm. Mohammad et al., Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model, ANTI-CANC D, 12(9), 2001, pp. 735-740
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma
Authors: Philip, PA Zalupski, MM Vaitkevicius, VK Arlauskas, P Chaplen, R Heilbrun, LK Adsay, V Weaver, D Shields, AF
Citation: Pa. Philip et al., Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma, CANCER, 92(3), 2001, pp. 569-577
A pilot study of increasing dose intensity of epirubicin and ifosfamide inpatients with small cell lung cancer by using recombinant granulocyte colony-stimulating factor
Authors: Philip, PA Rea, D Mitchell, K Carmichael, J Harris, AL Talbot, DC
Citation: Pa. Philip et al., A pilot study of increasing dose intensity of epirubicin and ifosfamide inpatients with small cell lung cancer by using recombinant granulocyte colony-stimulating factor, CL ONCOL-UK, 11(2), 1999, pp. 84-89
A phase II study of the modulation of 5-fluorouracil and folinic acid withhigh-dose infusional hydroxyurea in metastatic colorectal carcinoma
Authors: O'Byrne, KJ Philip, PA Propper, DJ Braybrooke, JP Saunders, MP Bates, NP Taylor, MA Madigan, D Ganesan, TS Talbot, DC Harris, AL
Citation: Kj. O'Byrne et al., A phase II study of the modulation of 5-fluorouracil and folinic acid withhigh-dose infusional hydroxyurea in metastatic colorectal carcinoma, ANN ONCOL, 10(8), 1999, pp. 981-983
Gemcitabine and UFT plus oral calcium folinate: Phase I study
Authors: Philip, PA Ibrahim, D Zalupski, M Arlauskas, P Shields, A
Citation: Pa. Philip et al., Gemcitabine and UFT plus oral calcium folinate: Phase I study, ONCOLOGY-NY, 13(7), 1999, pp. 116-119
Phase II study of CI-958 in colorectal cancer
Authors: Shields, AF Philip, PA LoRusso, PM Ferris, AM Zalupski, MM
Citation: Af. Shields et al., Phase II study of CI-958 in colorectal cancer, CANC CHEMOT, 43(2), 1999, pp. 162-164
Use of V79 cells with stably transfected cytochrome P450 cDNAs in studyingthe metabolism and effects of cytotoxic drugs
Authors: Philip, PA Ali-Sadat, S Doehmer, J Kocarek, T Akhtar, A Lu, H Chan, KK
Citation: Pa. Philip et al., Use of V79 cells with stably transfected cytochrome P450 cDNAs in studyingthe metabolism and effects of cytotoxic drugs, CANC CHEMOT, 43(1), 1999, pp. 59-67
Phase I study of the mitomycin C analogue BMS-181174
Authors: Macaulay, VM O'Byrne, KJ Green, JA Philip, PA McKinley, L LaCreta, FP Winograd, B Ganesan, TS Harris, AL Talbot, DC
Citation: Vm. Macaulay et al., Phase I study of the mitomycin C analogue BMS-181174, BR J CANC, 77(11), 1998, pp. 2020-2027
Risultati: 1-9 |